Dr. Sarah Fae Schillie, MD, MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 225 Rabro Dr E, Hauppauge, NY 11501 Phone: 631-853-3034 Fax: 631-853-3031 |
News Archive
Huntington Memorial Hospital's stroke program has received the Gold Seal of Approval from the Joint Commission, designating the hospital a primary stroke center. This means Huntington will join the network of "approved stroke center" hospitals throughout Los Angeles County.
The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors.
IDM Pharma, Inc. today announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.
A report released by the Asian Development Bank Wednesday examines how the global economic crisis is exacerbating poverty and hunger in regions of Asia, the Associated Press/Forbes writes.
› Verified 8 days ago